Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-16-017834)

Filing Details

Accession Number:: 0001179110-16-017834
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-01-19 17:06:26
Reporting Period:: 2016-01-19

Filing Date:: 2016-01-19
Accepted Time:: 2016-01-19 17:06:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1260990	Gtx Inc	GTXI	Pharmaceutical Preparations (2834)	621715807

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276243	Steven Marc Hanover	175 Toyota Plaza 7Th Floor Memphis TN 38103	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-01-19	25,000	$0.50	1,240,411	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	352,875	Indirect	By Limited Liability Company
Common Stock	62,007	Indirect	By Trust
Common Stock	62,007	Indirect	By Trust

Footnotes

An Aggregate of 25,000 shares of common stock were purchased in multiple trades on January 19, 2016 at prices ranging from $0.4899 to $0.50. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, GTx, Inc. or a shareholder of GTx, Inc. full information regarding the number of shares and prices at which the transaction was effected.